Date published: 2026-4-29

1-800-457-3801

SCBT Portrait Logo
Seach Input

Finasteride-d9 (CAS 98319-26-7 (unlabeled))

0.0(0)
Write a reviewAsk a question

See product citations (1)

Alternate Names:
(5α,17β)-N-(1,1-Dimethylethyl-d9)-3-oxo-4-azaandrost-1-ene-17-carboxamide; MK-906-d9; Proscar-d9; Prostide-d9; Finastid-d9
Application:
Finasteride-d9 is a labeled version of finasteride which inhibits 5α-reductase (the enzyme that converts testosterone to 5α-dihydrotestosterone)
CAS Number:
98319-26-7 (unlabeled)
Molecular Weight:
381.60
Molecular Formula:
C23H27D9N2O2
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

The labeled version of Finasteride. An inhibitor of 5α-reductase, the enzyme which converts testosterone to the more potent androgen, 5α-dihydrotestosterone. Antialopecia agent.


Finasteride-d9 (CAS 98319-26-7 (unlabeled)) References

  1. Finasteride-induced prostatic involution by apoptosis in dogs with benign prostatic hypertrophy.  |  Sirinarumitr, K., et al. 2002. Am J Vet Res. 63: 495-8. PMID: 11939309
  2. Steroid 5alpha-reductase inhibitors.  |  Flores, E., et al. 2003. Mini Rev Med Chem. 3: 225-37. PMID: 12570838
  3. Perifollicular fibrosis: pathogenetic role in androgenetic alopecia.  |  Yoo, HG., et al. 2006. Biol Pharm Bull. 29: 1246-50. PMID: 16755026
  4. Finasteride Increases the Expression of Hemoxygenase-1 (HO-1) and NF-E2-Related Factor-2 (Nrf2) Proteins in PC-3 Cells: Implication of Finasteride-Mediated High-Grade Prostate Tumor Occurrence.  |  Yun, DK., et al. 2013. Biomol Ther (Seoul). 21: 49-53. PMID: 24009858
  5. Finasteride: the first 5 alpha-reductase inhibitor.  |  Sudduth, SL. and Koronkowski, MJ. 1993. Pharmacotherapy. 13: 309-25; discussion 325-9. PMID: 7689728
  6. Efficacy and tolerability of finasteride in symptomatic benign prostatic hyperplasia: a primary care study. Primary Care Investigator Study Group.  |  Tenover, JL., et al. 1997. Clin Ther. 19: 243-58. PMID: 9152564
  7. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group.  |  McConnell, JD., et al. 1998. N Engl J Med. 338: 557-63. PMID: 9475762

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Finasteride-d9, 1 mg

sc-218478
1 mg
$337.00